GMP Compliance for Production of CB.Hep-1 Monoclonal Antibody as a Biological Reagent - - BioPharm International

ADVERTISEMENT

GMP Compliance for Production of CB.Hep-1 Monoclonal Antibody as a Biological Reagent

16. Valdés R., García J., Reyes B., Muñoz L., Alvarez T., Padilla S., Abrahantes M.C., Zubiaurrez J., Agraz A., Marrero A., "A Very Sensitive Enzyme-linked Immunoabsorbent Assay to Staphylococcal Protein A in the Presence of Immunoglobulins," Biochemical and Biophysical Research Communications, Volume 303, Issue 3, 11 April 2003, Pages 863-867.

17. Hardy E., Martínez E., Diago D., Díaz R., González D., Herrera L., "Large-scale Production of Recombinant Hepatitis B Surface Antigen from Pichia Pastoris," Journal of Biotechnology, 77: 157–167, 2000.

18. Werz W., Hoffmann H., Haberer K., Walter J.K., "Strategies to Avoid Virus Transmissions by Biopharmaceutic Products," 1997.

19. Janet B., Elizabeth M., and Alexander F, "Viral Removal/Inactivation by Purification of Biopharmaceuticals," Biopharm 5, No. 9 (Nov-Dec, 1992): 22-30.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

EMA Warns of Falsified Herceptin Vials
April 16, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
Author Guidelines
Source: BioPharm International,
Click here